ms and glp 1 GLP-1 RA Effects are Largely Homogeneous but Stronger in Women than Men, With Caleb Alexander, MD, Q&A 111: Glucagon-like peptide-1 receptor

In our latest text on autonomic dysfunction and mitochondrial dysfunction, we implicate oxidative stress to neurons in the P&S nervous system as being a major mechanism in causing disruption of the Autonomic function in patients who develop Dysautonomia

New perspectives on the treatment of hidradenitis suppurativa

Today, there is still a large number of GLP-1R agonists entering clinical trials, which will lead to a big explosion in the future, so let's wait and see together

Always wait the full 30 minutes to ensure optimal therapeutic benefit

Prediction #1: More Lawsuits Due to Adverse Effects The number of lawsuits against GLP-1 companies (like Novo Nordisk and Eli Lilly) has grown significantly, expanding from just 55 consolidated cases in early 2024 to more than 4,400 total cases by mid-2026 When I wrote the original piece, news outlets were reporting a few dozen lawsuits against manufacturers Novo Nordisk and Eli Lilly

Are these agents directly modulating immune pathways involved in psoriatic disease, or are they simply removing metabolic stressors that worsen inflammation